We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+66.19%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$455M
AUM Growth
+$57.7M
Cap. Flow
-$82.2M
Cap. Flow %
-18.09%
Top 10 Hldgs %
19.06%
Holding
153
New
50
Increased
18
Reduced
37
Closed
44
Avg Time Held
1.8 quarters
Top 10 Avg Time Held
0.3 quarters
Top 20 Avg Time Held
0.3 quarters

Top Buys

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$7.21M
2
CROX icon
Crocs
CROX
+$5.77M
3
CORT icon
Corcept Therapeutics
CORT
+$5.53M
4
CVLT icon
Commault Systems
CVLT
+$5.33M
5
EQPT icon
EquipmentShare.com Inc
EQPT
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 34.16%
2 Healthcare 25.57%
3 Industrials 23.22%
4 Consumer Discretionary 9.43%
5 Financials 2.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MAIR icon
101
Madison Air Solutions
MAIR
$12.1B
$1.37M 0.3%
+35,015
New +$1.36M
2026 Q2
0 quarters
LGN icon
102
Legence Corp
LGN
$3.68B
$1.33M 0.29%
+15,580
New +$1.27M
2026 Q2
0 quarters
CRDO icon
103
Credo Technology Group
CRDO
$37.3B
$1.14M 0.25%
+4,175
New +$825K
2026 Q2
0 quarters
APEI icon
104
American Public Education
APEI
$886M
$1.12M 0.25%
+20,895
New +$1.15M
2026 Q2
0 quarters
ATRO icon
105
Astronics
ATRO
$2.71B
$998K 0.22%
12,280
-36,704
-75% -$2.51M
2025 Q4
2 quarters
PI icon
106
Impinj
PI
$5.6B
$801K 0.18%
+5,595
New +$730K
2026 Q2
0 quarters
PL icon
107
Planet Labs
PL
$5.52B
$738K 0.16%
22,285
-190,140
-90% -$7.03M
2025 Q4
2 quarters
XPO icon
108
XPO
XPO
$21.2B
$643K 0.14%
3,130
– –
2025 Q3
3 quarters
QNT icon
109
Quantinuum Inc
QNT
$1.44B
$409K 0.09%
+5,005
New +$322K
2026 Q2
0 quarters
AEIS icon
110
Advanced Energy
AEIS
$11B
– –
-23,736
Closed -$7.66M –
ALHC icon
111
Alignment Healthcare
ALHC
$1.72B
– –
-130,280
Closed -$2.3M –
APGE icon
112
DELISTED
Apogee Therapeutics
APGE
– –
-52,260
Closed -$4.4M –
BBIO icon
113
BridgeBio Pharma
BBIO
$12.4B
– –
-31,405
Closed -$2.33M –
CAVA icon
114
CAVA Group
CAVA
$6.19B
– –
-50,510
Closed -$4.09M –
COHR icon
115
Coherent
COHR
$57.1B
– –
-4,020
Closed -$958K –
DNTH icon
116
Dianthus Therapeutics
DNTH
$4.34B
– –
-12,410
Closed -$1.04M –
ENSG icon
117
The Ensign Group
ENSG
$10.1B
– –
-30,810
Closed -$6.21M –
EYE icon
118
National Vision
EYE
$1.35B
– –
-196,953
Closed -$5.1M –
FCFS icon
119
FirstCash
FCFS
$9.49B
– –
-16,965
Closed -$3.19M –
FIGS icon
120
FIGS
FIGS
$2.99B
– –
-137,180
Closed -$2.03M –
FIVE icon
121
Five Below
FIVE
$11.7B
– –
-42,639
Closed -$9.74M –
FIX icon
122
Comfort Systems
FIX
$57.2B
– –
-1,390
Closed -$1.92M –
FN icon
123
Fabrinet
FN
$15.3B
– –
-12,165
Closed -$6.34M –
FRPT icon
124
Freshpet
FRPT
$3.18B
– –
-53,125
Closed -$3.13M –
GKOS icon
125
Glaukos
GKOS
$9.76B
– –
-6,995
Closed -$753K –

Similar funds

Lisanti Capital Growth's Q2 2026 Portfolio in Review

As of Q2 2026, Lisanti Capital Growth held 153 positions worth $455M, up 15% from $397M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Lisanti Capital Growth withdrew a net $82.2M in Q2 2026, closing 44 positions and reducing 37 holdings. Its most notable exit was Five Below, an estimated $9.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Xometry worth $9.74M.

  • Lisanti Capital Growth's largest Q2 2026 buy was Xometry: 100,880 shares worth $9.74M.
  • Lisanti Capital Growth added most to Hinge Health in Q2 2026, an estimated $4.34M increase.
  • Lisanti Capital Growth's biggest Q2 2026 reduction was Sterling Infrastructure, cutting an estimated $10.7M.
  • Lisanti Capital Growth fully exited Five Below in Q2 2026, selling an estimated $9.74M.
  • Lisanti Capital Growth's ten largest holdings make up 19% of its $455M portfolio in Q2 2026.
  • Lisanti Capital Growth opened 50 new positions and closed 44 in Q2 2026.
  • Lisanti Capital Growth's portfolio value rose 15% quarter-over-quarter to $455M.

Based on Lisanti Capital Growth's 13F filing for Q2 2026, filed 10 Aug 2026.